393 related articles for article (PubMed ID: 15944736)
1. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria.
Gressner O; Schilling T; Lorenz K; Schulze Schleithoff E; Koch A; Schulze-Bergkamen H; Lena AM; Candi E; Terrinoni A; Catani MV; Oren M; Melino G; Krammer PH; Stremmel W; Müller M
EMBO J; 2005 Jul; 24(13):2458-71. PubMed ID: 15944736
[TBL] [Abstract][Full Text] [Related]
2. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
Wu G; Nomoto S; Hoque MO; Dracheva T; Osada M; Lee CC; Dong SM; Guo Z; Benoit N; Cohen Y; Rechthand P; Califano J; Moon CS; Ratovitski E; Jen J; Sidransky D; Trink B
Cancer Res; 2003 May; 63(10):2351-7. PubMed ID: 12750249
[TBL] [Abstract][Full Text] [Related]
3. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
4. Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.
LeBlanc H; Lawrence D; Varfolomeev E; Totpal K; Morlan J; Schow P; Fong S; Schwall R; Sinicropi D; Ashkenazi A
Nat Med; 2002 Mar; 8(3):274-81. PubMed ID: 11875499
[TBL] [Abstract][Full Text] [Related]
5. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
[TBL] [Abstract][Full Text] [Related]
6. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
7. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
Wang S; El-Deiry WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
[TBL] [Abstract][Full Text] [Related]
8. Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively.
Porta C; Hadj-Slimane R; Nejmeddine M; Pampin M; Tovey MG; Espert L; Alvarez S; Chelbi-Alix MK
Oncogene; 2005 Jan; 24(4):605-15. PubMed ID: 15580300
[TBL] [Abstract][Full Text] [Related]
9. The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells.
Chin MY; Ng KC; Li G
Exp Cell Res; 2005 Apr; 304(2):531-43. PubMed ID: 15748897
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
[TBL] [Abstract][Full Text] [Related]
11. Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.
Mundt HM; Stremmel W; Melino G; Krammer PH; Schilling T; Müller M
Biochem Biophys Res Commun; 2010 May; 396(2):335-41. PubMed ID: 20403333
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
13. ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria.
Schuster A; Schilling T; De Laurenzi V; Koch AF; Seitz S; Staib F; Teufel A; Thorgeirsson SS; Galle P; Melino G; Stremmel W; Krammer PH; Müller M
Cell Cycle; 2010 Jul; 9(13):2629-39. PubMed ID: 20581467
[TBL] [Abstract][Full Text] [Related]
14. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
15. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
Dohn M; Zhang S; Chen X
Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein confers chemoresistance by blocking apoptosis signaling via death receptors and mitochondria.
Gagiannis S; Müller M; Uhlemann S; Koch A; Melino G; Krammer PH; Nawroth PP; Brune M; Schilling T
Int J Cancer; 2009 Oct; 125(7):1551-7. PubMed ID: 19507249
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha).
Sun R; Zhang Y; Lv Q; Liu B; Jin M; Zhang W; He Q; Deng M; Liu X; Li G; Li Y; Zhou G; Xie P; Xie X; Hu J; Duan Z
J Biol Chem; 2011 May; 286(18):15918-28. PubMed ID: 21367858
[TBL] [Abstract][Full Text] [Related]
18. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
19. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
20. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
